2020
DOI: 10.3390/cancers12123616
|View full text |Cite
|
Sign up to set email alerts
|

Update on the Management of Breast Cancer during Pregnancy

Abstract: The diagnosis of breast cancer during pregnancy represents a challenging situation for the patient, her caregivers and physicians. Pregnancy adds complexity to oncological treatment planning, as many therapies can be potentially dangerous to the fetus. Therefore, a multidisciplinary approach is needed to offer a proper care for obtaining the best possible outcomes for the mother and the future child. Breast surgery is feasible throughout the pregnancy while radiotherapy should be postponed after delivery. Admi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
48
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(50 citation statements)
references
References 86 publications
0
48
0
2
Order By: Relevance
“…Overall, 487 articles were identified and screened. After removal of 471 irrelevant articles, 9 reviews 10 , 11 , 12 , 23 , 24 , 25 , 26 , 27 , 28 and 3 non-English articles, 13 , 14 , 15 4 studies were considered eligible for our review. 29 , 30 , 31 , 32 Having investigated the references of the relevant reviews and eligible articles, two more articles were added.…”
Section: Resultsmentioning
confidence: 99%
“…Overall, 487 articles were identified and screened. After removal of 471 irrelevant articles, 9 reviews 10 , 11 , 12 , 23 , 24 , 25 , 26 , 27 , 28 and 3 non-English articles, 13 , 14 , 15 4 studies were considered eligible for our review. 29 , 30 , 31 , 32 Having investigated the references of the relevant reviews and eligible articles, two more articles were added.…”
Section: Resultsmentioning
confidence: 99%
“…Clinically significant levels of tamoxifen and its metabolites were found to accumulate in human milk over time; therefore, exposure to tamoxifen should be avoided during breastfeeding. 70 Enrollment is now complete to POSITIVE, a prospective cohort study in women with hormone receptor-positive, early-stage breast cancer desiring pregnancy after an initial 18 to 30 months of adjuvant endocrine therapy, for whom a break in therapy for up to 2 years to attempt pregnancy/delivery/lactation is allowed, with a plan for subsequent resumption of adjuvant endocrine therapy. Although not randomly assigned, outcomes in women in POSITIVE will be assessed, and there are outcomes for women with comparable age/ tumors/treatments in SOFT/TEXT who did not interrupt therapy for pregnancy attempt.…”
Section: Duration and Interruption And Type Of Adjuvant Ovarian Function Suppression In Premenopausal Patientsmentioning
confidence: 99%
“…Delayed diagnosis is responsible for the worse outcome of PrBC compared to pregnancy-unrelated breast cancer, but stage-normalized survival is not different from that of age-matched non-pregnant controls (7)(8)(9)(10)(11)(12). According to most guidelines, PrBC should be managed with the same protocols as breast cancer occurring in young non-pregnant women (1,2,(13)(14)(15)(16)(17)(18). However, the condition of pregnancy adds a layer of complexity to the treatment of PrBC because the benefit for the mother must not harm the fetus (2,13,(19)(20)(21)(22).…”
Section: Introductionmentioning
confidence: 99%
“…According to most guidelines, PrBC should be managed with the same protocols as breast cancer occurring in young non-pregnant women (1,2,(13)(14)(15)(16)(17)(18). However, the condition of pregnancy adds a layer of complexity to the treatment of PrBC because the benefit for the mother must not harm the fetus (2,13,(19)(20)(21)(22). For example, chemotherapy (CT) is contraindicated during the first trimester of gestation, while it can be safely administered in the second and third trimesters (23).…”
Section: Introductionmentioning
confidence: 99%